Literature DB >> 3909565

Cancer therapy: phenothiazines in an unexpected role.

G R Jones.   

Abstract

Four lines of evidence (clinical findings, epidemiology, inhibition of tumor growth together with prolongation of survival time, and mechanism of action) which suggest that certain phenothiazines, particularly chlorpromazine, possess a range of anti-neoplastic activities in man and in rodents which has not been generally recognised are reviewed and discussed. Chlorpromazine interferes with energy production in sensitive tumours; the mode of action appears to correspond to autooxidative cellular injury, a common form of cell death.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3909565     DOI: 10.1177/030089168507100608

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  5 in total

1.  Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells.

Authors:  I Yuan; Chi-Ting Horng; Vincent Chin-Hung Chen; Chun-Hung Chen; Li-Jeng Chen; Tsai-Ching Hsu; Bor-Show Tzang
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

2.  Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study.

Authors:  Cara Bergamo; Keith Sigel; Grace Mhango; Minal Kale; Juan P Wisnivesky
Journal:  Psychosom Med       Date:  2014-04       Impact factor: 4.312

3.  Cancer risk among users of neuroleptic medication: a population-based cohort study.

Authors:  S O Dalton; C Johansen; A H Poulsen; M Nørgaard; H T Sørensen; J K McLaughlin; P B Mortensen; S Friis
Journal:  Br J Cancer       Date:  2006-08-22       Impact factor: 7.640

4.  Chlorpromazine reduces UV-induced squamous cell carcinogenesis in hairless mice and enhances UV-induced DNA damage in cultured cells.

Authors:  M J Peak; M Pfaff; C Peraino
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

5.  Escitalopram oxalate induces apoptosis in U-87MG cells and autophagy in GBM8401 cells.

Authors:  Vincent Chin-Hung Chen; Yi-Hsien Hsieh; Li-Jeng Chen; Tsai-Ching Hsu; Bor-Show Tzang
Journal:  J Cell Mol Med       Date:  2017-11-03       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.